RecruitingNCT04914611
Real World Assessment of People Living With Chronic Hepatitis B in Australia
Sponsor
Kirby Institute
Enrollment
10,000 participants
Start Date
Feb 17, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The REACH-B study establishes an observational cohort study of people living with chronic hepatitis B from a national network, including a diverse range of services, to characterise and monitor hepatitis B linkage to care and treatment requirements amongst this population.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- All individuals diagnosed with chronic hepatitis B in the participating study sites are eligible to be included (both newly diagnosed cases and those diagnosed in the past).
- 16 years of age or older.
- Attended the health service for HBV care within the prior 12 months from study commencement (retrospective recruitment) OR Attending the health service for HBV care from study commencement (prospective recruitment)
Exclusion Criteria1
- \. Nil
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNo intervention
No intervention
Locations(19)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04914611
Related Trials
Evaluation of Patients With Liver Disease
NCT000019711 location
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
NCT038264331 location
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
NCT0539042411 locations
HepB mAb19 in Individuals With Chronic Hepatitis B Infection
NCT058568902 locations
National Liver Cancer Screening Trial
NCT0608423418 locations